Autophosphorylation and Pin1 binding coordinate DNA damage-induced HIPK2 activation and cell death

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 45, 2013, Pages

  Bitomsky, Nadja ^a   Conrad, Elisa ^a   Moritz, Christian ^b   Polonio Vallon, Tilman ^a   Sombroek, Dirk ^a   Schultheiss, Kathrin ^a   Glas, Carolina ^a   Greiner, Vera ^a   Herbel, Christoph ^a   Mantovani, Fiamma ^c,d   Del Sal, Giannino ^c,d   Peri, Francesca ^b   Hofmann, Thomas G ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^c Laborotorio Nazionale Consorzio Interuniversitario Biotecnologie AREA Science Park   (Italy)

^d UNIVERSITY OF TRIESTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HOMEODOMAIN INTERACTING PROTEIN KINASE 2; PEPTIDYLPROLYL ISOMERASE PIN1; PROTEIN; PROTEIN P53; SIAH 1 PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; AUTOPHOSPHORYLATION; BINDING AFFINITY; CELL DEATH; CONTROLLED STUDY; DNA DAMAGE; EMBRYO; ENZYME ACTIVATION; ENZYME REGULATION; HUMAN; HUMAN CELL; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; UBIQUITINATION; ZEBRA FISH;

APOPTOSIS; CARRIER PROTEINS; CELL LINE; DNA DAMAGE; ENZYME ACTIVATION; GENETIC VECTORS; HUMANS; MICROSCOPY, FLUORESCENCE; PEPTIDYLPROLYL ISOMERASE; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 84887307423     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1310001110     Document Type: Article

References (41)

1. Harper JW, Elledge SJ (2007) The DNA damage response: Ten years after. Mol Cell 28(5):739-745.
2. Oren M(2003) Decision making by p53: Life, death and cancer. Cell Death Differ 10(4): 431-442.
3. Brooks CL, Gu W (2006) p53 ubiquitination: Mdm2 and beyond. Mol Cell 21(3): 307-315.
4. Vousden KH, Prives C (2009) Blinded by the Light: The growing complexity of p53. Cell 137(3):413-431.
5. Hofmann TG, Glas C, Bitomsky N (2013) HIPK2: A tumour suppressor that controls DNA damage-induced cell fate and cytokinesis. Bioessays 35(1):55-64.
6. D'Orazi G, Rinaldo C, Soddu S (2012) Updates on HIPK2: A resourceful oncosuppressor for clearing cancer. J Exp Clin Cancer Res 31:63.
7. Pierantoni GM, et al. (2007) High-mobility group A1 inhibits p53 by cytoplasmic relocalization of its proapoptotic activator HIPK2. J Clin Invest 117(3):693-702.
8. Li XL, et al. (2007) Mutations of the HIPK2 gene in acute myeloid leukemia and myelodysplastic syndrome impair AML1- and p53-mediated transcription. Oncogene 26(51):7231-7239.
9. Mao JH, et al. (2012) Hipk2 cooperates with p53 to suppress γ-ray radiation-induced mouse thymic lymphoma. Oncogene 31(9):1176-1180.
10. Wei G, et al. (2007) HIPK2 represses beta-catenin-mediated transcription, epidermal stem cell expansion, and skin tumorigenesis. Proc Natl Acad Sci USA 104(32): 13040-13045.
11. Muschik D, et al. (2011) Cutaneous HPV23 E6 prevents p53 phosphorylation through interaction with HIPK2. PLoS ONE 6(11):e27655.
12. Jin Y, et al. (2012) A systems approach identifies HIPK2 as a key regulator of kidney fibrosis. Nat Med 18(4):580-588.
13. Zhang J, et al. (2007) Essential function of HIPK2 in TGFbeta-dependent survival of midbrain dopamine neurons. Nat Neurosci 10(1):77-86.
14. Hofmann TG, et al. (2002) Regulation of p53 activity by its interaction with homeodomain- interacting protein kinase-2. Nat Cell Biol 4(1):1-10.
15. D'Orazi G, et al. (2002) Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis. Nat Cell Biol 4(1):11-19.
16. Dauth I, Krüger J, Hofmann TG (2007) Homeodomain-interacting protein kinase 2 is the ionizing radiation-activated p53 serine 46 kinase and is regulated by ATM. Cancer Res 67(5):2274-2279.
17. Di Stefano V, Rinaldo C, Sacchi A, Soddu S, D'Orazi G (2004) Homeodomain-interacting protein kinase-2 activity and p53 phosphorylation are critical events for cisplatin- mediated apoptosis. Exp Cell Res 293(2):311-320.
18. Lazzari C, et al. (2011) HIPK2 phosphorylates ΔNp63α and promotes its degradation in response to DNA damage. Oncogene 30(48):4802-4813.
19. Zhang Q, Yoshimatsu Y, Hildebrand J, Frisch SM, Goodman RH (2003) Homeodomain interacting protein kinase 2 promotes apoptosis by downregulating the transcriptional corepressor CtBP. Cell 115(2):177-186.
20. Gresko E, et al. (2006) Autoregulatory control of the p53 response by caspase-mediated processing of HIPK2. EMBO J 25(9):1883-1894.
21. Choi DW, et al. (2008) Ubiquitination and degradation of homeodomain-interacting protein kinase 2 by WD40 repeat/SOCS box protein WSB-1. J Biol Chem 283(8): 4682-4689.
22. Winter M, et al. (2008) Control of HIPK2 stability by ubiquitin ligase Siah-1 and checkpoint kinases ATM and ATR. Nat Cell Biol 10(7):812-824.
23. Kim SY, Choi DW, Kim EA, Choi CY (2009) Stabilization of HIPK2 by escape from proteasomal degradation mediated by the E3 ubiquitin ligase Siah1. Cancer Lett 279(2):177-184.
24. Rui Y, et al. (2004) Axin stimulates p53 functions by activation of HIPK2 kinase through multimeric complex formation. EMBO J 23(23):4583-4594.
25. Kurz EU, Douglas P, Lees-Miller SP (2004) Doxorubicin activates ATM-dependent phosphorylation of multiple downstream targets in part through the generation of reactive oxygen species. J Biol Chem 279(51):53272-53281.
26. Sorrentino G, et al. (2013) The prolyl-isomerase Pin1 activates the mitochondrial death program of p53. Cell Death Differ 20(2):198-208.
27. Sidi S, et al. (2008) Chk1 suppresses a caspase-2 apoptotic response to DNA damage that bypasses p53, Bcl-2, and caspase-3. Cell 133(5):864-877.
28. Lu KP, Zhou XZ (2007) The prolyl isomerase PIN1: A pivotal new twist in phosphorylation signalling and disease. Nat Rev Mol Cell Biol 8(11):904-916.
29. Siepi F, Gatti V, Camerini S, Crescenzi M, Soddu S (2013) HIPK2 catalytic activity and subcellular localization are regulated by activation-loop Y354 autophosphorylation. Biochim Biophys Acta 1833(6):1443-1453.
30. Saul VV, et al. (2013) HIPK2 kinase activity depends on cis-autophosphorylation of its activation loop. J Mol Cell Biol 5(1):27-38.
31. Bode AM, Dong Z (2004) Post-translational modification of p53 in tumorigenesis. Nat Rev Cancer 4(10):793-805.
32. Oda K, et al. (2000) p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell 102(6):849-862.
33. Zacchi P, et al. (2002) The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults. Nature 419(6909):853-857.
34. Zheng H, et al. (2002) The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response. Nature 419(6909):849-853.
35. Wulf GM, Liou YC, Ryo A, Lee SW, Lu KP (2002) Role of Pin1 in the regulation of p53 stability and p21 transactivation, and cell cycle checkpoints in response to DNA damage. J Biol Chem 277(50):47976-47979.
36. Krieghoff-Henning E, Hofmann TG (2008) HIPK2 and cancer cell resistance to therapy. Future Oncol 4(6):751-754.
37. Girardini JE, et al. (2011) A Pin1/mutant p53 axis promotes aggressiveness in breast cancer. Cancer Cell 20(1):79-91.
38. Hofmann TG, Stollberg N, Schmitz ML, Will H (2003) HIPK2 regulates transforming growth factor-beta-induced c-Jun NH(2)-terminal kinase activation and apoptosis in human hepatoma cells. Cancer Res 63(23):8271-8277.
39. Liou YC, Zhou XZ, Lu KP (2011) Prolyl isomerase Pin1 as a molecular switch to determine the fate of phosphoproteins. Trends Biochem Sci 36(10):501-514.
40. Bunz F, et al. (1998) Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282(5393):1497-1501.
41. Crone J, et al. (2011) Zyxin is a critical regulator of the apoptotic HIPK2-p53 signaling axis. Cancer Res 71(6):2350-2359